We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00354523
Recruitment Status : Terminated (Study closed following Phase I portion, insufficient activity to continue to Phase II.)
First Posted : July 20, 2006
Last Update Posted : December 17, 2014
Novartis Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2006
  Study Completion Date : August 2013